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Abstract The microorganisms that inhabit humans are
very diverse on different body sites and tracts. Each
specific niche contains a unique composition of the mi-
croorganisms that are important for a balanced human
physiology. Microbial cells outnumber human cells by
tenfold and they function as an invisible organ that is called
the microbiome. Excessive use of antibiotics and unhealthy
diets pose a serious danger to the composition of the mi-
crobiome. An imbalance in the microbial community may
cause pathological conditions of the digestive system such
as obesity, cancer and inflammatory bowel disease; of the
skin such as atopic dermatitis, psoriasis and acne and of the
cardiovascular system such as atherosclerosis. An unbal-
anced microbiome has also been associated with
neurodevelopmental disorders such as autism and multiple
sclerosis. While the microbiome has a strong impact on the
development of the host immune system, it is suspected
that it can also be the cause of certain autoimmune dis-
eases, including diabetes or rheumatoid arthritis. Despite
the enormous progress in the field, the interactions between
the human body and its microbiome still remain largely
unknown. A better characterization of the interactions may
allow for a deeper understanding of human disease states
and help to elucidate a possible association between the
composition of the microbiome and certain pathologies.
This review focuses on general findings that are related to
the area and provides no detailed information about the
case of study. The aim is to give some initial insight on the
studies of the microbiome and its connection with human
health.
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Introduction
The human body has generally been regarded as a self-
sustaining organism that can regulate all of its life pro-
cesses. However, over the past several years, researchers
have shown that the human body resembles an ecosystem
that consists of trillions of bacteria and other microorgan-
isms. It is likely that the human ecosystem is the result of
the evolutionary co-existence between the microbial com-
munity and the human body. Microorganisms inhabit
almost every corner of the human body, including the
gastrointestinal, respiratory, urogenital tracts and the skin.
They are involved in important physiology functions in
humans, such as digestion and the stimulation of the im-
mune system (Ackerman 2012).
The composition of the human microbiome (microbiota)
is highly personal and, therefore, it is challenging to clearly
define ‘‘a healthy microbiome’’. It was shown that the di-
versity in the composition of the microbiome among the
body sites is greater than it is between individuals. This
indicates that the human microbiome is highly variable
ecosystem that possesses diverse microbiological parts
(Proctor 2011; Ursell et al. 2012). However, it is possible to
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define ‘‘the core’’ of a healthy microbiome that occurs
frequently within different body sites.
The human digestive system is a very complicated system
that is composed of functionally distinct regions: the oral
cavity, stomach, small intestine and colon. The human oral
cavity is the perfect habitat for microorganisms due to the
abundance of nutrients. The mouth is home to at least six
billion microorganisms that belong to the Firmicutes (Gram
positive; e.g., Bacilli, Clostridia), Proteobacteria (Gram
negative, e.g., Salmonella, Escherichia, Helicobacter and
Yersinia), Bacteroidetes (e.g., Prevotella, Bacteroides),
Actinobacteria (Gram positive, e.g., Actinomyces, Strepto-
myces) and Fusobacteria (Gram negative, e.g.,
Fusobacterium) (Dave et al. 2012). Studies on gastric mi-
croflora have shown that it is composed mostly of
Actinobacteria, but because of the acidic environment,
Helicobacter (e.g.,H. pylori) is also present (Bik et al. 2006).
The small intestine microflora is qualitatively similar to the
colon microbiome, but the latter contains more microor-
ganisms. The proximal part of the small intestine contains
relatively few bacteria, and mainly composed of Gram-
positive Lactobacillus and Enterococcus faecalis. More
microorganisms occur in the distal part, e.g., coliforms and
Bacteroides. Nine major types of bacteria are found in the
colon, although quantitatively Firmicutes and Bacteroidetes
were dominant. At the genus level, anaerobic Bacteroides
and anaerobic lactic acid bacteria, e.g., Bifidobacterium bi-
fidum, prevailed (Dave et al. 2012). The microbiome of the
gut performs extremely important functions for the normal
development and functioning of the human body. These
functions include the synthesis of vitamins, the decomposi-
tion of chemicals and nutrients, the support of fat
metabolism, the outcompeting of pathogens, the promotion
of angiogenesis and the maintenance of homeostasis and the
development of the immune system (Holmes et al. 2011).
Analysis of the 16S rDNA sequences of the skin
demonstrated that it is occupied by 19 phyla, but that the
majority of the sequences was allocated to four phyla:
Actinobacteria (51.8 %), Firmicutes (24.4 %), Proteobac-
teria (16.5 %) and Bacteroidetes (6.3 %). These dominant
phyla were also present in the gut microbiome, but in
different proportions. The most abundant were Co-
rynebacteria (22.8 %—Actinobacteria), Propionibacteria
(23.0 %—Actinobacteria) and Staphylococci (16.8 %—
Firmicutes) (Grice et al. 2009; Grice and Segre 2011).
The human microbiota is altered over time due to the
changing lifestyles of people. The excessive use of antibi-
otics and unhealthy diets pose a serious danger to the
composition of the microbiome. At the same time, these
factors destabilize the homeostasis of the microbiome as
well as the homeostasis of the human body (Ursell et al.
2012). This microbiota has been extensively studied as part
of many international research projects such as the Human
Microbiome Project (HMP; www.hmpdacc.org), which was
launched in October 2007 by the National Institutes of
Health. The HMP brought together a huge number of experts
and researchers to (1) characterize the communities of mi-
croorganisms that are found in the major ecological niches in
humans, (2) assess the ecology of microbial metabolic and
functional pathways, (3) understand the mechanisms that are
responsible for the differences and similarities in the mi-
crobes people share and (4) determine their functional roles
in health maintenance and disease development. These re-
searches have led to over 350 papers (Gevers et al. 2012;
Human Microbiome Project 2012a, b; Koren et al. 2013;
www.ploscollections.org/hmp). Depending on the choices
of parameters, the HMP estimates that the human micro-
biome contains between 3,500 and 35,000 Operational
Taxonomic Units (OTUs). An OTU is a cluster of organisms
that are grouped based on sequence similarity (Human Mi-
crobiome Project 2012a). In addition, the HMP discovered
several novel taxa at the genus level. The abundance of these
novel OTUs were\2 %, but they were present in significant
number of volunteers. The novel taxa included the Dorea,
Oscillibacter and Desulfovibrio genera, which correlated
with disease states (colorectal adenoma, dietary shifts and
opportunistic infections, respectively), the Barnesiella
genus and a possible novel family within Clostridiales
(Human Microbiome Project 2012a; Morgan et al. 2013;
Wylie et al. 2012). Moreover, the HMP has supported the
development of new technological tools and bioinformatics
that allowed, e.g., whole-genome shotgun metagenomic
data to be composed (Ravel et al. 2014). These data enable
the universality of the concept of enterotypes in the human
microbiota to be analyzed. It has been estimated that there
are three distinct ecosystems—enterotypes in the human gut
microbiome. These enterotypes vary in species, functional
composition and enzyme balance. It has also been demon-
strated inter alia that the enzymes which are associated with
the biotin biosynthesis pathway are overrepresented in En-
terotype 1, while those which are connected with the
thiamine and heme biosynthesis pathways are dominant in
Enterotype 2 and 3, respectively (Arumugam et al. 2011).
Koren et al. (2013) use the term ‘‘enterotype’’ not only
within microbial types in the gut, but also for different body
sites. It was found that most samples fell into gradients that
are based on bacterial taxonomic abundances. It was also
determined that some body niches show a bimodal or mul-
timodal distribution of the abundances of samples across the
gradients (Koren et al. 2013).
Despite the huge progress in the field, the interactions
between the human body and its microbiome still remain
largely unknown (Ursell et al. 2012). Nevertheless, it is
very important to highlight the larger role that the human
microbiota plays in the development and maintenance of
disease states.
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Digestive System
Obesity
Traditionally, obesity is associated with energy disorders
and an excessive intake of nutrients that is sometimes
combined with a genetic predisposition. Recent studies
have provided new information about the microbiome in
the gut, especially its role in gaining an understanding of
the pathogenesis of obesity. Observations have focused on
the role of the gut microbiome in the development of
obesity using rodent models (Harley and Karp 2012;
Holmes et al. 2011).
It has been shown that the consumption of high-fat
products reduces the total volume of the intestinal micro-
biome and induces the growth of Gram-negative bacteria
(Holmes et al. 2011). According to this, there is a corre-
lation between the composition of the microbiome and
obesity. The intestinal microbiome differs between normal
mice and obese mice, particularly in relation to the pro-
portion of two bacterial groups—Firmicutes and
Bacteroidetes. Obese mice exhibited a 50 % lower fre-
quency of Bacteroidetes and an increased proportion of
Firmicutes. Additionally, a significant increase in the
number of genes that are associated with the use of energy
from food was observed in the same population of obese
mice. Consequently, scientists focused on initial studies of
obese patients who were on a low-calorie diet. These
analyses confirmed the results that had been obtained in the
gut microbiome of mice. While an individual is on a diet,
the frequency of Bacteroidetes increases, while the pro-
portion of Firmicutes declines relative to the initial value.
After losing weight for a year, the proportion of Firmicutes
and Bacteroidetes in their intestinal microbiome was
comparable with that found in slim individuals (Ley et al.
2005; Tlaskalova´-Hogenova´ et al. 2011). Other studies
showed that germ-free (GF) mice are not as likely to gain
weight as slim ones—despite consuming the same amount
of fat and carbohydrates. When they were colonized with
the microbiome from obese mice, there was a tendency of
faster fat deposition in comparison to the colonization with
the microbiome from slim mice (Turnbaugh et al. 2008).
Since the correlation between the microbiome and
obesity in rodent models has been established, scientists
have focused on initial studies among humans. An analysis
of 16S rRNA was performed on patients who were on a
low-calorie diet. These analyses confirmed the results that
had been obtained in the gut microbiome of mice—if obese
patients lost weight over a period of a year, the proportion
of Firmicutes and Bacteroidetes in their intestinal micro-
biome was comparable with that found in slim individuals
(Harley and Karp 2012; Ley et al. 2006).
Studies have also shown that the gut microbiome con-
trols an important gut-derived protein that is associated
with host lipid metabolism, which is an angiopoietin-like
protein 4 (Angptl4) that is also known as Fiaf. Angptl4
regulates the oxidation of fatty acid in both muscle and
adipose tissue. When GF mice were colonized with the
microbiome from obese rodents, the production of Angptl4
was suppressed in the intestine and more triglycerides were
deposited in adipose tissue (which leads to a weight gain).
Studies among humans have shown that a functional ang-
ptl4 gene variant was more common in patients who had
relatively low levels of triglycerides. Angptl4 can be an
important regulator of lipid metabolism in humans (Ba¨ck-
hed et al. 2007; Ley 2010).
Many studies include the correlation between the pres-
ence of Helicobacter pylori and obesity. The presence of
H. pylori causes a postprandial decrease of ghrelin, a peptide
hormone that is involved in the regulation of appetite. Gastric
secretion of ghrelin significantly increased after the
eradication of the bacterium and caused weight gain.
Although the connection between H. pylori and obesity has
been demonstrated in numerous studies, the role of ghrelin in
the regulation of this process is still unclear. Further studies
are needed to clarify the interaction between the factors that
mediate weight gain and the eradication of the bacterium
from the human body (Boltin and Niv 2012).
It was recently established that the endotoxin-producing
Enterobacter induces obesity and insulin resistance in GF
mice. During clinical studies, in a morbidly obese volun-
teer (weight 174.8 kg), who was suffering from serious
metabolic deterioration, Enterobacter represented 35 % of
his gut bacteria. After a diet, this amount decreased to less
than 1.8 %. Further studies were performed on GF mice on
a high-fat diet that were colonized with Enterobacter strain
(E. cloacae B29) that had been isolated from the gut of an
obese volunteer. Obesity and insulin resistance were ob-
served in these mice. According to these studies on human-
derived Enterobacter in GF mice, this bacterium may be
involved in the development of obesity in humans (Fei and
Zhao 2012).
Gastrointestinal Cancers
According to the studies and experimental animal models,
there is also a correlation between the composition of the
gut microbiome and gastrointestinal cancers. It has been
shown that the Western-style diet (a great deal of red meat
and fat coupled with a low intake of vegetables) changes
the intestinal microbiome—by increasing the activity of
bacterial enzymes and the metabolism of bile acid. They
can produce carcinogens or metabolize certain compounds
into biologically active ones, which may play a role in
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carcinogenesis (Tlaskalova´-Hogenova´ et al. 2011; Van-
nucci et al. 2009). Examples of these are the heterocyclic
amines that are found in grilled meat, which are digested
by bacteria in the colon and converted into electrophilic
derivatives that can damage DNA and increase the risk of
colon cancer. A high protein diet also provides the sulfur-
reducing bacteria (such as Desulfovibrio vulgaris) with raw
materials for the creation of harmful compounds—such as
hydrogen sulfide. It can also damage DNA and increase the
risk of colorectal cancer (Huycke and Gaskins 2004; Rooks
and Garrett 2011). The highest production of carcinogens
was associated with intestinal anaerobes and was reduced
by supplementation with Lactobacillus (Chung et al. 1992).
Other effects of the Western diet also include changes in
the bile composition—by increasing the proportion of
secondary bile acids, which are the products of the trans-
formation of primary ones by intestinal bacteria. One of
these, deoxycholic acid, is associated with several models
of carcinogenesis and the enzymatic activity of 7a-dehy-
droxylating bacteria (some Clostridia), which may be a
target in the study of risk factors for gastrointestinal tumors
(Holmes et al. 2011; Reddy et al. 1996).
A H. pylori infection has been recognized as a major
risk factor for gastric cancer. Although more than 50 % of
the world’s population is infected with this bacterium, less
than 2 % of population develops cancer. Therefore, there
are probably other risk factors (such as genetic, lifestyle,
environmental or epigenetic aspects) that may play a role
in the development of the disease (Conteduca et al. 2013).
An infection of the gastric mucosa by H. pylori creates
conditions that are favorable for the development of ulcers
and lymphoma, which change the paths of mucin produc-
tion, metaplasia and proliferation. These abnormalities are
described in gastric and colorectal cancer (Babu et al.
2006; Tlaskalova´-Hogenova´ et al. 2011). It was recently
shown that variations in specific intestinal microbiome
members affects an H. pylori-triggered inflammation. An-
tibiotic-treated mice were resistant to the inflammation and
the alternations in the intestinal microbiome resulted in a
decreased amount of Th1, which suggests a reduction in the
Th1-promoting microbe or increased amounts of a Th1-
inhibiting species. Furthermore, these mice had more
Clostridium spp. (cluster IV and XIVa), which can prevent
inflammation in the intestine by altering the recruitment of
regulatory T cells to the gastric compartment. These indi-
cate that manipulations of the gastric microbiome can set a
new direction in the diagnosis and prevention of H. pylori-
associated infections, e.g., gastric cancer (Rolig et al.
2013).
The composition of the intestinal microbiome is im-
portant for the appropriate homeostasis of the human body.
Studies have shown that microorganisms can also affect the
health of an organism in an indirect way. Several diseases
of the digestive tract are connected with the immune sys-
tem and its production of the relevant components. One of
these disorders is inflammatory bowel disease (IBD).
Inflammatory Bowel Disease
IBD is a chronic, relapsing inflammation of the gastroin-
testinal tract that results in a disruption of immune
tolerance to the intestinal microflora and leads to mucosal
damage in individuals who are genetically predisposed.
Crohn’s disease (CD) and ulcerative colitis are usually
included in IBD, although these two illnesses have a dif-
ferent pathogenesis and inflammatory profile (Fava and
Danese 2011). The composition of the intestinal microflora
and its activity in patients with IBD differ from the norm,
mainly because of a lower incidence of dominant com-
mensals (e.g., Firmicutes, Bacteroides, Bifidobacterium). A
low number of Firmicutes leads to a decrease in the
population of Clostridium of the IXa and IV groups, which
are the main butyrate-producing bacteria. Butyrate affects
the inhibition of the NF-jB (nuclear factor of kappa light
polypeptide gene enhancer in B cells), thereby lowering the
levels of pro-inflammatory cytokines. The NF-jB is a
signaling module that plays a critical role in the immune
system (e.g., regulates the expression of cytokines).
Simultaneously, there is an increase in the occurrence of
Proteobacteria and Actinobacteria, which are harmful
sulfate-reducing bacteria as well as some Escherichia coli
(Fava and Danese 2011; Frank et al. 2007).
The efficacy of the intestinal mucosa depends on an
undamaged epithelium, secretion of antimicrobial peptides
(e.g., defensins, IgA) and phagocytosis. The mucosal de-
fense mechanisms are disturbed at all of these levels in
IBD, which can lead to the progression of the disease.
When membrane defensins and IgA decrease, there is an
abnormal phagocytosis and hyperactivity of the immune
response, which are considered to be the basis of the
pathogenesis of IBD. The effect of commensal Bacteroides
fragilis on IBD has also been investigated. The polysac-
charide (PSA) molecule that is produced by this bacterium
seems to suppress Th17 cells, which leads to a decrease in
the pro-inflammatory response that causes colitis. Th17
cells produce interleukin (IL)-17, which is found at the
elevated levels during an episode of the inflammation of
the mucous membrane of patients (Mazmanian et al. 2008;
Troy and Kasper 2010).
Some of the symptoms of CD are associated with
polymorphisms in the NOD2/CARD15 gene (single nu-
cleotide-binding oligomerisation caspase recruitment
domain 15). The product of this gene, NOD2 protein, is a
receptor that is present on the surface of host cells and it is
involved in the regulation of the production of pro-in-
flammatory NF-jB-dependent factors. The activation of
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NOD2 by the peptidoglycan of the bacterial cell wall leads
to the expression of a-defensins. Its expression was sig-
nificantly inhibited within the small intestine in patients
with CD (Binek 2012; Franczuk and Jagusztyn-Krynicka
2012; Kobayashi et al. 2005).
Experimental data have shown that single nucleotide
polymorphisms in the NOD2 gene are not the only cause of
the disease’s symptoms. E. coli, which has been detected in
tissues of patients with CD, shows atypical peculiarities
(both phenotypic and genotypic) (Baumgart et al. 2007).
According to the pathogenic properties of the bacteria, it
was called AIECE (adherent-invasive E. coli) and was
found to be a new E. coli pathotype. This pathotype is able
to invade inside the cells of the mucosa epithelium, where
it changes the cell metabolism by disrupting the secretion
of cytokines and interleukins. They may also be involved
in causing inflammation (Boudeau et al. 1999). Not only
are adherent-invasive strains of E. coli in the list of po-
tential etiological factors of CD. Among others, these
factors may be, e.g., the presence of Listeria monocyto-
genes, H. pylori and Mycobacterium avium subsp.
paratuberculosis. The etiology of CD requires further
studies (Fava and Danese 2011; Franczuk and Jagusztyn-
Krynicka 2012).
Other studies have also suggested that IBD is associated
with dysbiosis, which is characterized by changes in
populations between Firmicutes and Proteobacteria. The
question of whether this unbalance is a cause or a conse-
quence of the intestinal inflammation requires further
studies. It is very likely that dysbiosis, which is the lack of
beneficial bacteria and a genetic predisposition, increases
the permeability of the epithelium, impairs the immune
response and causes a loss of tolerance to natural mi-
croflora. Additional approaches are needed including
transcriptomics, proteomics, metabolomics and dietetics to
determine the impact of changes in the human microbiome
and the effects of specific mechanisms that result from the
metabolic activity of microorganisms (Fava and Danese
2011; Morgan et al. 2012).
Integumentary System
The integumentary system consists of the largest organ in
the body, the skin and its associated structures, such as the
hair and nails. The skin is colonized by a diverse collection
of microorganisms including bacteria, fungi and viruses.
The composition of the skin microbiome is complex, site-
specific and depends on the location on the skin and its
physiology (Grice and Segre 2011). To understand the
bacterial influence on human health, scientists began to
analyze the microbiome of the skin in several pathological
conditions, such as atopic dermatitis (AD; also called
eczema), psoriasis and acne (Kong 2011). All of these
diseases appear to be directly connected with changes in
the composition of the microbial community.
Atopic Dermatitis
AD is a chronic, relapsing and intensely pruritic inflam-
matory skin disorder. It affects more than 15 % of children
and 2 % of adults in the United States and 38 % and 10 %
in Poland, respectively (http://www.naukawpolsce.pap.pl).
The number of children suffering from this disease has
been on the rise (almost tripled) in industrialized countries
over the past 30 years, which suggests the influence of
environmental factors (Kong et al. 2012).
Studies that are focused on the presence of Staphylo-
coccus aureus on the skin of patients and healthy
individuals have shown that in about 90 % of patients who
suffer from AD, S. aureus affected both healthy and un-
healthy areas of the body. By contrast, S. aureus was very
rare on the skin of individuals who were not affected by the
disease. Moreover, when a patient’s condition worsens, S.
aureus often surpasses the entire community of microor-
ganisms, thereby reducing the microbial diversity of the
skin (Iwase et al. 2010; Kong et al. 2012). Metagenomics
has shown that the proportion of Staphylococcus species
that are present in the skin microbiome increased from 35
to 90 %, but surprisingly in addition to S. aureus, S. epi-
dermidis was also involved. The latter can produce
molecules that selectively inhibit S. aureus, which suggests
an antagonistic relationship, even though both of these
species may also interact mutualistically to strengthen their
intestinal colonization (Iwase et al. 2010; Stecher et al.
2010). It is not exactly clear whether these Staphylococcus
species promote each other’s growth or whether the growth
of S. epidermidis is a response to the growing population of
S. aureus. Understanding the implications of S. aureus on
the skin microbiome can set a new course for the treatment
of AD, which would be based on the manipulation of the
composition of the skin’s microbiome and not only on the
elimination of this bacteria (Chen and Tsao 2013; Kong
et al. 2012).
Psoriasis
There are some tested and proven methods for AD treat-
ment including antibiotics or steroids, but there are no
effective antimicrobial treatments for psoriasis (Trivedi
2012). Psoriasis is a common chronic inflammatory disease
of the skin that is present in about 2 % of the world’s
population (Scho¨n and Boehncke 2005). The causes of this
illness are poorly understood. It has been suggested that S.
aureus and Streptococcus pyogenes infections might play a
role in psoriasis, but treatment against Streptococcus was
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not effective and did not cure or relieve the disease state
(Kong 2011; Weisenseel and Prinz 2005).
16S rDNA PCR for Archaea and bacteria was performed
to examine the microbiome of normal and psoriatic skin. A
greater variety of skin microflora was observed in ill pa-
tients, compared to healthy patients. The phylum
Firmicutes was significantly overrepresented compared to
the samples from uninvolved skin (both of the patients and
healthy individuals). Actinobacteria were more numerous
on the skin of healthy individuals and underrepresented in
the psoriatic lesion samples, while the number of Pro-
teobacteria was higher on the skin of the ill patients. A
greater number of Staphylococci and a reduced number of
Propionibacterium (P. acnes in particular) were also re-
ported in the patients with psoriasis when compared to
healthy individuals (Fahle´n et al. 2012; Gao et al. 2008).
Therefore, it has been suggested that the disease not only
depends on fluctuations of the skin microbiome, but also
appears to result from a combination of genetic and envi-
ronmental factors (Gao et al. 2008; Kong 2011).
Acne
Acne is a common skin disease that affects 85 % of teen-
agers (Webster 2002). It is well known that acne is
associated with the occurrence of Propionibacterium acnes
on the skin of patients who suffer from this ailment.
Genotypic identification of microorganisms on skin (16S
rRNA analysis) of healthy people and of patients with acne
showed that healthy hair follicles contain only P. acnes,
while the hair follicles in patients with acne are colonized
by a mixture of S. epidermidis, Corynebacterium spp. and
P. acnes (which predominated) (Bek-Thomsen et al. 2008).
To better understand the strain diversity of P. acnes and
their different roles in the disease, the genomes of 82
strains were compared. According to the results, acne was
caused by certain strains of a species rather than the entire
species, which is in line with the studies of other diseases
(Kong and Segre 2012; Tomida et al. 2013).
It has recently been shown that skin that is inhabited by
P. acnes can be divided into two populations—epidermal
and follicular. To date, it has not been proven that epi-
dermal P. acnes is an inflammatory trigger, but when it is
present in hair follicles, it may contribute to inflammatory
changes, e.g., acne. The conditions that are related to this
process are as yet unknown (Alexeyev and Jahns 2012;
Bojar and Holland 2004).
It is believed that microorganisms might be connected in
the development of various skin disorders. Many aspects of
the possible role of microbes in diseases of the skin and
their cooperation with genetic and environmental changes
are still unknown and further studies are warranted (Kong
and Segre 2012).
Bacterial communities of the skin are also involved in
immune homeostasis and inflammatory responses. It has
been established that staphylococcal lipoteichoic acid
(LTA) inhibits inflammation of the skin. LTA inhibits both
the release of inflammatory cytokine from keratinocytes
and the inflammation that is caused by an injury that is
connected with Toll-like receptor 2 (Capone et al. 2011;
Lai et al. 2009). It has been suggested that the immune
pathways that are associated with the skin microbiome are
linked to the development of allergies and asthma (Benn
et al. 2002; Callard and Harper 2007; Capone et al. 2011).
Immune System
The microbiome is essential in the activation of the host
immune response and many autoimmune diseases result
from a disturbance of the adaptive immune system. The
frequency of autoimmune type 1 diabetes (T1D) and
rheumatoid arthritis (RA) is increasing, which suggests that
there has been a change in the environmental factors that
regulate this system. An unbalanced diet, the widespread
use of antibiotics and other social factors in developed
countries may cause changes in the human microbiome and
dysbiosis (Lee and Mazmanian 2010). The intestinal mi-
crobiome in healthy individuals is important and plays a
unique role in the human body. This microbiome has been
associated inter alia with metabolic functions (such as the
digestion of various compounds and xenobiotics), in pro-
tective functions (i.e., the inhibition of an invasion of
pathogens and the strengthening of the integrity of the
epithelium) and in the modulation of the immune system
(e.g., intestinal epithelial homeostasis) (Fava and Danese
2011).
Studies have shown the critical role that the immune
system receptor (MyD88) plays in the recognition of mi-
crobes that occurs in immune homeostasis. MyD88-
dependent bacterial signals induce the repair of a damaged
intestinal epithelium (Pull et al. 2005) and promote the
induction of epithelial antimicrobial proteins such as
RegIIIc. The expression of RegIIIc may be triggered by
lipopolysaccharide or flagellin (Brandl et al. 2007; Hooper
et al. 2012; Kinnebrew et al. 2010).
The commensals that are present in the human body
may induce the differentiation of CD4? T cells into the
four main types: Th1, Th2, Th17 and Treg (regulatory T
cells). Each type has a different role in the immune system
and secretes characteristic cytokines (e.g., interleukins).
Th1 cells are involved in the elimination of intracellular
pathogens and Th2 cells control parasitic contagion. Th17
cells play an important role in the control of infections,
while Tregs regulate the immune response (Wu and Wu
2012).
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The human microbiota modulates the proper balance
between these four cell types. It has been established that
segmented filamentous bacteria (SFB) play a role in the
induction of Th17 and Th1 cells (Ivanov et al. 2009). Other
bacteria (e.g., some Clostridia strains) increase the abun-
dance of Treg cells and induce the expression of the
inducible T cell co-stimulator and IL-10, which are im-
portant anti-inflammatory molecules (Atarashi et al. 2013).
SFBs induce many intestinal immune responses that
support Th17 cell differentiation, such as the production of
cytokines and chemokines, antimicrobial peptides and
serum amyloid A. The colonization of animals by SFBs
protects them from a Citrobacter rodentium infection that
causes inflammation similar to enteropathogenic E. coli in
humans (Lee and Mazmanian 2010; Snel et al. 1998).
Moreover, Bacteroides fragilis has a beneficial effect
on the balance of the immune system. B. fragilis has
become a model for the study of the correlation between
symbiotic bacteria and the immune system. Bacterial
PSA, which are produced by B. fragilis, stimulate the
development of Treg cells and the production of increased
amounts of IL-10. PSA is able to prevent and treat ex-
perimental autoimmune encephalomyelitis (EAE). This
treatment results in an inhibition of pro-inflammatory cells
and in an increase in the Treg numbers in the central
nervous system (CNS). This suggests that the presence of
B. fragilis is sufficient to determine the proper balance of
Th1/Th2. Dysregulation of Th1 or Th17 activity may lead
to autoimmune diseases, while overactivity of Th2 may be
one of the causes of asthma and allergies (Ackerman
2012; Lee and Mazmanian 2010; Mazmanian et al. 2005;
Troy and Kasper 2010).
Type 1 Diabetes
An imbalance between Firmicutes and Bacteroidetes and a
low diversity in the gut microbiome may cause T1D, which
is also called insulin-dependent diabetes. It is a disease that
results from the T cell-mediated slow destruction of insulin
producing islet b cells in the pancreas. Firmicutes (more
specifically Lactobacillus, which is present in the human
body) induces Treg in the large intestine, as well as other
organs, and supports the immune system homeostasis.
Decreased amounts of Treg cells have been reported in
patients with T1D, which suggests the participation of the
intestinal microbiome in the development of the disease
(Livingston et al. 2010; Romano-Keeler et al. 2012; Wu
and Wu 2012). Furthermore, it has been proposed that
Lactobacillus johnsonii may delay the progression of T1D
by stimulating the development of Th17 (Boerner and
Sarvetnick 2011; Vaarala 2011).
Experimental evidence has shown that non-obese
diabetic (NOD) mice that lack the innate microbial-
recognition immune system receptor, MyD88, are resistant
to T1D. The protective effect of MyD88 deficiency re-
quires the presence of the gut microbiome, since mice that
were lacking MyD88 NOD readily developed diabetes in a
GF facility. These results indicate that the protective effect
of MyD88 deficiency is due to the induction of MyD88-
independent signaling due to the expansion of beneficial
bacteria (Wen et al. 2008; Wu and Wu 2012).
Rheumatoid Arthritis
RA is an autoimmune disease that causes the chronic in-
flammation of the joints. Patients with this disorder display
an abnormal circulation of Treg cells and an increased
number of Th17 and IL-17 in the plasma and synovial fluid
of the knee (Hot and Miossec 2011; Scher and Abramson
2011). On the other hand, infections of enteric pathogens
such as Salmonella, Yersinia and Shigella can trigger au-
toimmune reactions in the joints and reactive arthritis as
sequelae (Toivanen 2003). Many studies have tried to
pinpoint the arthritogenic molecules of the bacteria; urease
subunits of Yersinia have been suggested as an arthrito-
genic factor in a rat model (Gripenberg-Lerche et al. 2000).
In addition, patients with RA had higher levels of anti-
bodies against certain species of intestinal bacteria (e.g.,
Proteus) and Klebsiella, which suggests that there is a link
between this bacteria and RA (Ebringer et al. 2010; Rashid
and Ebringer 2007). Moreover, some antibiotics (e.g.,
sulfasalazine and minocycline) are reported to have a
therapeutic effect for some patients, which may be related
to the antibacterial activity of these molecules (Wu and Wu
2012).
The intestinal microbiome dysbiosis in susceptible in-
dividuals can potentially lead to a pro-inflammatory
response that damages tissue (e.g., connective tissue of the
joints) (Scher and Abramson 2011).
Cardiovascular System
Atherosclerosis
Atherosclerosis is a progressive process that causes focal
thickening of muscular and large elastic arteries. Studies
have shown a connection between periodontitis, Chlamydia
pneumoniae and H. pylori infections and atherosclerosis
(Desvarieux et al. 2005). Because of those relationships,
attempts have been made to treat atherosclerosis with an-
tibiotics. The results have not led to any consensus
regarding the effect of antibiotics in preventing or reducing
atherosclerosis. Studies using anti-chlamydial antibiotics
have also not demonstrated any positive effects in patients
with arterial disease (Jaff et al. 2009; Muhlestein 2003).
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Bacteria from the oral cavity may affect atherosclerosis by
promoting low-grade inflammation. Almost all of the pe-
riodontal bacteria were detected in the atheromatous plaque
samples that had been obtained from periodontitis patients.
Their DNA constituted 47.3 % of the total bacterial DNA
in the samples. Prevotella intermedia, Porphyromonas
gingivalis and Actinobacillus actinomycetemcomitans were
frequently identified in the plaques from patients with pe-
riodontitis, while P. gingivalis was the only targeted
microorganism that was observed in these plaques from
healthy subjects. According to these studies, the oral pe-
riodontopathic bacteria that are present in atherosclerotic
tissue samples may contribute to the development of vas-
cular diseases (Gaetti-Jardim et al. 2009).
Furthermore, researchers have shown that the micro-
biome may be important for the initiation, but not for the
progression, of atherosclerosis (Caesar et al. 2010). Ex-
perimental studies using apolipoprotein E-deficient mice
(ApoE-/-) attempted to confirm this. It has been shown
that conventionally reared ApoE-/- mice that had been fed
a low-fat diet do not tend to develop atherosclerotic pla-
ques, in contrast to the same type of mice that had been
reared in GF conditions (Caesar et al. 2010). Differences in
atherosclerotic plaques are not as apparent when mice are
fed a high-fat diet that is supplemented with cholesterol
(Stepankova et al. 2010). It was also demonstrated that the
GF ApoE-/- mice had slightly reduced atherosclerosis
after 22 weeks of high-fat feeding (Wright et al. 2000).
These results document that there is a connection between
the microbiome and the development of atherosclerosis
(Tlaskalova´-Hogenova´ et al. 2011).
Nervous System
Several neuropathological diseases are thought to be as-
sociated with the gut microbiome because of the
interactions of the CNS and the gut (gut-brain axis). Neu-
ral, immunological and endocrinological mechanisms are
involved in this communication. The enteric nervous sys-
tem directly controls the functions of the gastrointestinal
tract (Collins and Bercik 2009; Tlaskalova´-Hogenova´ et al.
2011).
The use of GF mice has enabled the impact of the
gastrointestinal microbiome and probiotics on behavior and
behavioral abnormalities, including anxiety to be studied
(Cryan and O’Mahony 2011). Studies suggest that the
colonization of the gut microbiome has become integrated
into the programming of brain development, thus affecting
motor control and anxiety-like behavior. GF mice had in-
creased motor activity and reduced anxiety, compared with
specific pathogen-free mice with a normal gut microbiome.
This is associated with changes in expression of the genes
that are involved in the second messenger pathways and
synaptic long-term potentiation in specific brain regions
(Diaz-Heijtz et al. 2011).
There are several studies that have linked the compo-
sition of the microbiome to psychiatric disorders, such as
autism spectrum disorders (which include autism) and
multiple sclerosis (MS). This association also appears to be
related to the metabolites of dietary components, in which
the microbiome plays a major role (Gonzalez et al. 2011).
Autism
Autism spectrum disorders (ASD) is a group of complex
neurodevelopmental dysfunctions that are characterized by
impairments in social interaction and communication, as
well as repetitive behaviors. ASD include several disorders,
one of which is autism. Autism is a neurodevelopmental
ailment of a complex origin that is defined by social, cog-
nitive and behavioral dysfunctions. In recent years, the
incidence rate has begun to rise, which points to the envi-
ronment as a contributing factor of autism. Environmental
factors include exposure to certain chemicals, drugs, stress,
infections (also maternal) and dietary agents (Dietert et al.
2011; Holmes et al. 2011; Louis 2012).
A prominent subset of ASD patients suffers from gas-
trointestinal (GI) symptoms for unknown reasons, which
points to the role of gut microbiome in this disorder (Be-
nach et al. 2012). The evidence of the microbial influence
on ASD is supported by the fact that interventions using
antibiotics and probiotics have positive effects on behavior
and the neuropsychological symptoms (Critchfield et al.
2011). Such studies provided the evidence that Sutterella
species are present in the ileal mucosal biopsy specimens
from autistic patients, but not from healthy children with
GI symptoms. This suggests that Sutterella may play a role
in this disorder (Williams et al. 2012). Furthermore, a
greater abundance of Ruminococcus torques was observed
in the fecal samples of children with ASD and GI symp-
toms (Wang et al. 2013).
Some reports have indicated that fecal microbial profiles
of autistic children are characterized by tenfold higher
numbers of Clostridium spp. compared with healthy sub-
jects (Finegold et al. 2002). Some Clostridium species
(such as C. histolyticum), which are known to produce
neurotoxins, occurred more frequently in the fecal samples
from ASD children when compared to unrelated healthy
individuals (Gonzalez et al. 2011; Parracho et al. 2005;
Sekirov et al. 2010). In addition, the metabolism of Clos-
tridium species may play a role in pathogenesis of autism.
Treatment of regressive-onset autistic children with the
antibiotic vancomycin resulted in improved behavior and
communication skills. However, these gains were tempo-
rary and only lasted while the children were undergoing
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treatment. These studies suggest that autism may be con-
nected with intestinal bacterial species that are sensitive to
vancomycin (Critchfield et al. 2011; Sandler et al. 2000).
Moreover, multiple dysbiosis in fecal microbiome was
also observed. At the phylum level, the proportion of
Bacteroidetes increased, while the level of Firmicutes was
lower (Finegold et al. 2010). Desulfovibrio was also found
in significantly higher numbers in severely autistic children
than in the controls, in contrast to some Bifidobacterium
species, which decreased (Adams et al. 2011; Finegold
2011). Autism is also associated with metabolic alterations
and microbial cometabolism. These include higher urinary
levels of hippurate and phenylacetylglutamine, perturba-
tions in sulfur, amino acid metabolism and the tryptophan/
nicotinic acid metabolic pathway (Iebba et al. 2011; Yap
et al. 2010).
A recent study showed the absence of B. fragilis in mice
with the autism-like disorders compared to the wild type.
When these mice were colonized with B. fragilis through
food, both behavioral problems and gastrointestinal diffi-
culties diminished. This finding can be useful not only in
autism, but also in other neurodevelopmental disorders
(Hsiao et al. 2013).
The fecal microbiome and metabolome of children with
autism were established by pyrosequencing of the 16S rDNA
and 16S rRNA. The highest microbial diversity was found in
AD children. These results confirmed most of the earlier
findings, including the amounts of Bacteroidetes, Firmi-
cutes, Saturella and Clostridium in the microbiome of
autistic children compared to healthy children. Furthermore,
the levels of other Clostridia-related genera (Caloramator
and Sarcina), Enterobacteriaceae, as well as Alistipes and
Akkermansia species were higher in AD children compared
to healthy ones. Conversely, Eubacteriaceae (except for
Eubacterium siraeum) and Bifidobacterium species were
found at lower level (De Angelis et al. 2013).
Multiple Sclerosis
Experimental autoimmune encephalomyelitis (EAE) is a
mouse model of multiple sclerosis (MS) in which an au-
toimmune response causes demyelination in the central
nervous system (CNS). The pathological mechanism of
EAE may differ significantly from human MS, but it can
still give valuable information about the role of the mi-
crobiome in these diseases (Wu and Wu 2012). Bacterial
involvement in the pathogenesis of MS was suggested
because of the presence of bacterial peptidoglycan within
the antigen presenting cells in the brains of patients. The
earlier mentioned PSA, which is produced by B. fragilis, is
able to prevent EAE by inhibiting pro-inflammatory cells,
while increasing the amount of regulatory T cells in the
CNS. Modification of the commensal bacteria by
antibiotics modulates the peripheral immune tolerance that
can protect against EAE and significantly weaken the dis-
ease. The protection is associated with a reduction of pro-
inflammatory cytokines and an increase in IL-10 and IL-13
levels (Ochoa-Repa´raz et al. 2009; Tlaskalova´-Hogenova´
et al. 2011).
The lower production of pro-inflammatory cytokines,
such as IL-17, was observed in GF mice. These rodents
were colonized with SFBs, which are known to induce
Th17 cells in the gut. Increased Th17 cell responses and the
occurrence of EAE were reported after the colonization.
These studies suggest that the microbiome is composed of
organisms that can direct both pro- and anti-inflammatory
immune responses in the CNS (Lee et al. 2011; Wu and
Wu 2012).
There is evidence that Clostridium perfringens may be
involved in inflammations (Rumah et al. 2013). Some C.
perfringens species (e.g., type B and D) are known to
produce epsilon toxin, which appears to be an MS trigger in
individuals with a genetic predisposition. According to
some studies, this toxin causes blood brain barrier perme-
ability, kills oligodendrocytes and also targets the retinal
vascular and meningeal cells that are involved in MS in-
flammation (Dorca-Are´valo et al. 2008, 2012; Rumah et al.
2013).
Conclusion
The human microbiome is a remarkably variable ecosys-
tem that has various microbiological niches whose
diversity within body sites is greater than that between
individuals. The role of the microbiome in human health
has been studied by many international teams of scientists.
The Human Microbiome Project is an interdisciplinary and
global project, the main goal of which is to comprehend the
microbial components and their influence on homeostasis
and a predisposition to disease. The symbiosis between the
human host and the microbiome maintains specific
physiological responses. Shifts in the latter can impair
many of those, so that they result in a variety of chronic,
localized, sometimes acute and systemic human diseases,
e.g., IBD, cancer, obesity and autism. The growing
awareness of the importance of the microbiome in health
and disease and a more comprehensive analysis of it may
pave the way to a more complete knowledge of human
physiology and to treating the human body as a ‘‘super-
organism’’, a complex ecosystem in which each part
interacts and communicates with the others.
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